関連する実験動画
Updated: Jul 14, 2026

07:51
A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
Published on: June 18, 2018
オピオイド依存症の治療における中等量対高用量メタドン:ランダム化試験
E C Strain1, G E Bigelow, I A Liebson
1Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. ecsgss@aol.com
JAMA
|March 23, 1999
まとめ
高用量メタドン塩化水素による治療は,中程度の用量と比較して,オピオイド依存症の患者における違法オピオイド使用を著しく減少させた. 両方の投与量は解毒と維持に役立ちましたが,高用量のメタドンは違法なオピオイドの使用を減らすのにより大きな効果を示しました.
科学分野:
- 依存症医学 薬物中毒医学
- 薬理学 薬理学とは
- クリニック・トライアル 臨床試験
背景:
- メタドン塩化水素は,オピオイド依存症の主要な薬理学的治療法です.
- 専門診療所を超えてメタドン治療へのアクセスを拡大することに関心が高まっている.
- より高いメタドン用量を調査する制御試験は不足しています.
研究 の 目的:
- オピオイド依存症の治療における中等用量メタドンと高用量メタドンの臨床効果を比較する.
- 違法オピオイド使用と治療の継続に対する異なるメタドン用量の影響を評価する.
主な方法:
- 1992年6月から1995年10月まで40週間のランダム化,ダブルブラインド臨床試験が実施されました.
- 外来薬物乱用研究クリニックの資格のある患者192人は,カウンセリングとともに,毎日口服メタドン塩化水素 (40-50 mgまたは80-100 mg) を受けていました.
- 主なアウトカム指標には,オピオイド陽性尿検査結果と治療継続が含まれていました.
主要な成果:
- 高用量メタドン (80~100mg) を投与された患者は,中量投与群 (53.0%対61.9%,P=0.047) と比較して,第30週までにオピオイド陽性尿サンプルが有意に低い割合を示した.
- これらの違法オピオイド使用の減少は,メタドン離脱期間中に持続しました.
- グループ間の治療継続において有意な差は認められなかった (平均継続期間は159日対157日).
- 高用量グループでは解毒の完了率が高く (33%対20%).
結論:
- メタドン塩化水素の適度量および高用量の両方が,メンテナンスおよび解毒の間に違法オピオイドの使用を効果的に減少させた.
- 高用量メタドン治療は,オピオイド依存症の患者の間で違法オピオイドの使用を減らすのに優れた有効性を示しました.
関連する概念動画
Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Time Course of Drug Effect
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...

